Astellas Pharma Canada Revenue and Competitors

CAN

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Astellas Pharma Canada's estimated annual revenue is currently $22.7M per year.(i)
  • Astellas Pharma Canada's estimated revenue per employee is $201,000

Employee Data

  • Astellas Pharma Canada has 113 Employees.(i)
  • Astellas Pharma Canada grew their employee count by 10% last year.

Astellas Pharma Canada's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.8M34-41%N/AN/A
#2
$88M4389%N/AN/A
#3
$86.8M43224%N/AN/A
#4
$53.1M2640%N/AN/A
#5
$1.2M60%N/AN/A
#6
$14.3M716%N/AN/A
#7
$43.8M2186%N/AN/A
#8
$2.2M110%N/AN/A
#9
$23.3M1166%N/AN/A
#10
$36.2M18031%N/AN/A
Add Company

What Is Astellas Pharma Canada?

Astellas Pharma Canada, Inc., a Canadian affiliate of Tokyo-based Astellas Pharma Inc., is a pharmaceutical company dedicated to changing tomorrow by improving the health of people around the world through innovative and reliable pharmaceutical products. In 2005, Astellas was formed by blending the talents, resources and passions of two highly successful firms - Yamanouchi and Fujisawa. Astellas aims to maintain and strengthen our position as the global leader in transplantation and urology areas, and going forward we are working to establish our position as a global category leader in oncology. At all levels throughout the company our people are committed to the opportunity to positively affect and improve patient lives while remaining socially responsible to our community and those with whom we work and collaborate.

keywords:N/A

N/A

Total Funding

113

Number of Employees

$22.7M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Astellas Pharma Canada News

2022-04-19 - Astellas Abandons Tumultuous Gene Therapy Program, Loses $390M

In September 2021, Astellas Pharma reported a fourth patient death ... tested in more than 1,020 women with VMS across 280 sites in Canada,...

2022-04-17 - Astellas Announces Reimbursement for XOSPATA® (gilteritinib) in ...

Astellas Pharma Canada, Inc. is a Canadian affiliate of Tokyo-based Astellas Pharma Inc., a pharmaceutical company conducting business in...

2022-04-17 - Vasopressin Market Size And Forecast | Par Pharmaceutical, Pfizer ...

Par Pharmaceutical, Pfizer, Novartis, Ferring Pharmaceuticals, Fresenius Kabi Canada, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals. The...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M11310%N/A
#2
$16.4M113N/AN/A
#3
$36.7M11326%N/A
#4
$7.9M113-21%N/A
#5
$11.3M1138%N/A